Načítá se...
Perampanel for focal epilepsy: insights from early clinical experience
Perampanel is approved for adjunctive therapy of focal epilepsy with or without secondarily generalized seizures in patients aged >12 years. This narrative review uses real‐world and clinical trial data to elucidate perampanel's role in the clinic. Audit data show good tolerability with pera...
Uloženo v:
| Vydáno v: | Acta Neurol Scand |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4738453/ https://ncbi.nlm.nih.gov/pubmed/26506904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ane.12529 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|